Virtual therapeutic psychedelic clinic Tripsitter $KETA/$KETA.C has announced the appointment of Alexander Somjen to their board.
Somjen brings experience as the former president of a publicly-traded company and the current CEO of an investment firm focused on early-stage investment opportunities in the psychedelic sector.
As the therapeutic psychedelic industry starts to see more normalization in the medical field, I’m really interested in the companies that are taking advantage of the tele-medicine space in order to expand their operations. The ability for patients to be treated with therapeutic psychedelics at home in a comfortable environment should make the entire experience much more inviting to prospective patients.
Shares of $KETA have taken a bit of a dive since IPO and are currently trading at $.48. As the entire sector has taken quite a dip in recent months, I think this was to be expected. All this says to me is that we’re seeing a great opportunity to scoop up some discounted shares in the near future.
Once the industry starts to see more public acceptance and growth, we’ll be looking at an easy 200% gain in shares of $KETA should they make it back to the IPO price alone.
$KETA is currently valued at an $MCAP of $14.52 million.
https://www.newswire.ca/news-releases/tripsitter-clinic-ltd-announces-appointment-of-alexander-somjen-817258828.html